Spiriva Respimat

Boehringer Ingelheim Pharmaceuticals, Inc.🇺🇸 United States

FDA Page

Effective Date: Aug 17, 2026
Approval ID: 7b656b14-fcaa-2741-f6f0-e0be48971c02
Products: 2 registered
Version: 16

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use SPIRIVA RESPIMAT safely and effectively. See full prescribing information for SPIRIVA RESPIMAT. SPIRIVA RESPIMAT (tiotropium bromide inhalation spray), for oral inhalation use Initial U.S. Approval: 2004

Quick Stats

Total Products2

Labelers2

Label Sections19

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.